Variables | Univariate analysis | Regression coefficient (ß) | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||||
Sex | |||||||
Female | 0.940 | (0.662–1.335) | 0.731 | ||||
Age (year) | 1.024 | (1.012–1.037) | < 0.001 | ||||
Etiology | |||||||
Non-Viral | ref | ||||||
Viral | 0.616 | (0.437–0.870) | 0.006 | ||||
Child-Pugh class | |||||||
A | ref | ||||||
B | 1.591 | (1.143–2.213) | 0.006 | ||||
ALBI grade | |||||||
1 | ref | ||||||
2 | 2.231 | (1.605–3.101) | <.0001 | ||||
3 | 6.602 | (3.409–12.786) | <.0001 | 0.832 | 2.299 | (1.694–3.119) | <.0001 |
HAP score | |||||||
A-C | ref | ||||||
D | 3.937 | (2.872–5.399) | <.0001 | ||||
Modified HAP score | |||||||
A-C | ref | ||||||
D | 4.689 | (3.012–7.300) | <.0001 | ||||
Tumor number | |||||||
≤3 | ref | ||||||
> 3 | 1.615 | (1.155–2.259) | 0.005 | ||||
Tumor size (cm) | |||||||
< 3 | ref | ||||||
3–4 | 1.775 | (1.231–2.560) | 0.002 | ||||
≥5 | 3.359 | (2.368–4.763) | <.0001 | 0.533 | 1.704 | (1.424–2.038) | <.0001 |
Hemoglobin (g/dL) | 0.851 | (0.796–0.909) | <.0001 | ||||
Log WBC | 1.452 | (0.988–2.132) | 0.058 | ||||
Log platelet | 1.165 | (0.875–1.551) | 0.296 | ||||
Log prothrombin time (INR) | 9.847 | (3.454–28.076) | <.0001 | ||||
Log creatinine | 1.907 | (1.377–2.640) | <.0001 | ||||
Sodium | 0.937 | (0.898–0.977) | 0.002 | ||||
Log AST | 2.332 | (1.833–2.966) | <.0001 | ||||
Log ALT | 1.231 | (1.010–1.499) | 0.039 | ||||
Log Total bilirubin | 1.191 | (0.900–1.574) | 0.221 | ||||
Alpha-fetoprotein | |||||||
< 200 | ref | ||||||
≥200 | 1.774 | (1.313–2.397) | <.0001 | 0.460 | 1.583 | (1.164–2.154) | 0.0034 |
NLR | 1.91 | (1.444–2.525) | <.0001 | ||||
Tumor response | |||||||
CR + PR | ref | ||||||
SD + PD | 2.292 | (1.733–3.032) | <.0001 | 0.650 | 1.915 | (1.431–2.563) | <.0001 |